(NZW x BXSB)F1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction.
about
Association between anti-nucleophosmin and anti-cardiolipin antibodies in (NZW x BXSB)F1 mice and human systemic lupus erythematosusThe role of the gut microbiota in the pathogenesis of antiphospholipid syndromeMethotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammationInduction of microthrombotic thrombocytopenia in normal mice by transferring a platelet-reactive, monoclonal anti-gp70 autoantibody established from MRL/lpr mice: an autoimmune model of thrombotic thrombocytopenic purpura.CTLA4Ig prevents initiation but not evolution of anti-phospholipid syndrome in NZW/BXSB mice.(NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura.Calorie restriction prevents the occlusive coronary vascular disease of autoimmune (NZW x BXSB)F1 miceAutoimmune-prone (NZW x BXSB)F1 (W/BF1) mice escape severe thrombocytopenia after treatment with deoxyspergualin, an immunosuppressant.Accelerated atheroma and anti-beta2-glycoprotein I antibodies.Lessons from BXSB and related mouse models.The Yaa gene abrogates the major histocompatibility complex association of murine lupus in (NZB x BXSB)F1 hybrid miceContribution of V(H) replacement products in mouse antibody repertoire.Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks.Pathophysiology of the antiphospholipid antibody syndrome.High frequency of spontaneous acute myocardial infarction due to small coronary artery disease in dead (NZWxBXSB)F1 male mice.Mononuclear-cell pulmonary vasculitis in NZB/W mice. I. Histopathologic evaluation of spontaneously occurring pulmonary infiltrates.Quantitative analysis of myocardial infarction in (NZW x BXSB)F1 hybrid mice with systemic lupus erythematosus and small coronary artery diseaseLow-calorie diet selectively reduces expression of retroviral envelope glycoprotein gp70 in sera of NZB x NZW F1 hybrid mice.Antiphospholipid antibodies: laboratory and pathogenetic aspects.Protein Z, protein Z-dependent protease inhibitor (serpinA10), and the acute-phase response.Soluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndromeThe pathophysiology of hypertension in systemic lupus erythematosus.Inhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndromeMolecular studies of lupus nephritis kidneys.Understanding mechanisms of hypertension in systemic lupus erythematosus.Interactions of immune function with lipids and atherosclerosis.The Yaa gene model of systemic lupus erythematosus.Cutaneous manifestations of Behçet's disease.Anticardiolipin antibodies in NZW x BXSB F1 mice.Models for central nervous system complications of antiphospholipid syndrome.The role of the Yaa gene in lupus syndrome.Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?Cellular immunology in a historical perspective.High mortality rate of (NZW x BXSB)F1 mice induced by administration of lipopolysaccharide attributes to high production of tumour necrosis factor-alpha by increased numbers of dendritic cells.
P2860
Q24813018-BF6E878B-DD47-48DF-940A-ADB4134F6370Q26866133-6E6F7507-2B21-461C-A0C0-AD596CBEF315Q27320563-6AD27AF2-99BE-4C00-9BDB-EF956083264CQ33331009-F2BB10EF-A3F1-4F3D-9FB5-100E8BC4D2F6Q33364310-C0B8C54D-B9DA-4EC9-B50B-BB1E386F3AA7Q33449588-27B3AA7D-94E6-4B17-9548-BA46B8D5E9B1Q33492697-21A8FE91-0710-4E3A-B7F1-D0D891167034Q33495166-2D48364D-A6F4-441D-84FE-62ADD8BE3464Q33915467-DA6569AC-9B95-4F56-90EC-55AB79128C66Q34052004-EE5FE6EA-3E61-4DE3-BA8C-766BAFD52E61Q34228567-032CFE71-238C-416E-8FF0-072F027AA68AQ34612574-71285EAF-387D-451C-ACD3-969B8F25659CQ35027749-B4FF77EA-9AD5-401F-9A63-78BCD1C262A4Q35309024-1D0E18F1-0F4F-4717-AF8D-1B52603CA0C2Q35818114-42425073-F1EA-4107-BE24-0E4DACDCEB6AQ35835246-6FA555E1-4A1E-4198-AB36-48505986919AQ35856536-732F1A80-D4A4-49FA-BB4C-BA5CC24B9C9FQ36345700-C1E472A6-7DCD-4D55-B0C0-052685FCECA2Q36799474-A3AA7A4E-935F-488A-B944-A650C3D019C2Q36954455-E3AE4DC0-1F1A-4FA6-8042-704647FD9170Q37204282-C69D3B3A-9DE8-46E1-9F94-C9ED80651DB8Q37233020-E436761F-2FAA-445A-B046-DFC2A8D9220EQ37585221-8353B377-C934-4A2F-B47F-091E196C0B6DQ38588001-8B4F29D1-9D1C-4105-A2C5-E0A13B00B48CQ38777852-8244FAF3-A94D-4446-8B01-74008D61A716Q40157817-F17D3ED6-FCD9-4D0C-BF81-4DF70BC672CDQ40433196-1205EAFD-9CCC-48B8-950B-BEB490A67D0AQ40525967-1F1FE0F5-DF22-4D6E-8727-D6AAC2E6CA07Q40558488-3D99BDA5-1FD1-43F6-AD24-183EF6B9493CQ40558504-E602E47B-925B-40FA-92AD-BB8929BCBC9CQ40635201-D25F8C38-D1D8-4A68-89B6-FD5165676071Q46677340-B0B997FA-E9A7-4A41-9117-54AD2058A363Q51843846-E9F57D6F-A5A8-4FA1-B5F0-B2FB2D1CBC29Q54516556-3146C66F-96E8-4F44-8A48-5D9D7C259390
P2860
(NZW x BXSB)F1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh
1981年學術文章
@zh-hant
name
(NZW x BXSB)F1 hybrid. A model ...... se with myocardial infarction.
@ast
(NZW x BXSB)F1 hybrid. A model ...... se with myocardial infarction.
@en
type
label
(NZW x BXSB)F1 hybrid. A model ...... se with myocardial infarction.
@ast
(NZW x BXSB)F1 hybrid. A model ...... se with myocardial infarction.
@en
prefLabel
(NZW x BXSB)F1 hybrid. A model ...... se with myocardial infarction.
@ast
(NZW x BXSB)F1 hybrid. A model ...... se with myocardial infarction.
@en
P2093
P2860
P356
P1476
(NZW x BXSB)F1 hybrid. A model ...... se with myocardial infarction.
@en
P2093
P2860
P304
P356
10.1084/JEM.154.1.216
P407
P577
1981-07-01T00:00:00Z